Intermedix acquires EMSystems

Jeff Byers | | Health Imaging | Artificial Intelligence
Health IT company Intermedix has acquired health IT company EMSystems for an undisclosed amount.

Milwaukee-based EMSystems will operate under the trade name Intermedix EMSystems as a division of Intermedix, stated Intermedix, of Fort Lauderdale, Fla.

EMSystems develops and markets web-based applications that help emergency healthcare providers and public health stakeholders prepare for, detect, respond to and provide care for emergencies.

Andy Nunemaker, who has led EMSystems as CEO since 2004, will serve as president of Intermedix EMSystems and, along with the EMSystems management team, will develop and market emergency healthcare technology systems for the combined companies, Intermedix added.

Jeff Byers

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.